← Open Payments lookup

SOUMYA PHILIP: Open Payments

NPI 1750866133 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 36 payments from 10 companies in 2025. Trend: 2023 $820 · 2024 $866 · 2025 $781

Food & beverage: $782
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$199
Amgen Inc.9$158
BridgeBio Pharma, Inc.3$95
Novartis Pharmaceuticals Corporation3$81
E.R. Squibb & Sons, L.L.C.3$72
Boehringer Ingelheim Pharmaceuticals, Inc.3$62
Bayer Healthcare Pharmaceuticals Inc.2$55
Cleerly, Inc.1$24
Boston Scientific Corporation1$23
CVRx, Inc.1$11

Products named: FARXIGA, REPATHA, Attruby, LEQVIO, ELIQUIS, JARDIANCE, Kerendia, WAINUA.

Industry payments across TX — which companies pay providers there.